While Uttar Pradesh has sought 10 million doses (five million each from Serum Institute and Bharat Biotech), Maharashtra is looking to procure 15 million and is floating a global tender for this. Vaccine makers, however, say states are seeking to procure the products at Rs 150 per dose after the Centre said it would continue to get them at that price.
However, Maharashtra is yet to firm up its views on free doses. While Maharashtra Health Minister Rajesh Tope had earlier ruled out free vaccination for all, Minority Affairs Minister Nawab Malik indicated on Sunday the government would give free doses to residents in Maharashtra.
States would have to fund procurement from their own budgets and bridge funding from the Centre is unlikely. “As of now we estimate that the state will have to spend around Rs 5,000 crore on procuring vaccines. We will negotiate prices with vaccine manufacturers and try to get them at a lower price than the one declared by them,” said a Maharashtra government official.
States have, nonetheless, started indicating their immediate requirements to vaccine makers. Most states have formed high-level committees comprising ministers and bureaucrats who will decide on the number of beneficiaries, expenditure on free vaccination drive, pricing strategy, etc.
West Bengal health department officials said the mode of procurement for the 18-44 age group was under discussion. “Discussions are being held at every level,” one of them said.
The Ministry of Health and Family Welfare has said it would continue to buy the two vaccines – Covishield and Covaxin – at Rs 150 per dose. The Centre will supply the doses it supplies states for free. The Centre will continue to pick up the tab for those above 45 years if they visit a government hospital or vaccination centre for the jab. States have to procure for those above 18 and citizens also have the option to pay for a shot in a private hospital.
Both companies have announced the prices at which private hospitals can buy the vaccines — Rs 600 (Covishield) and Rs 1,200 (Covaxin).
To read the full story, Subscribe Now at just Rs 249 a month
Already a subscriber? Log in
Subscribe To BS Premium
₹249
Renews automatically
₹1699₹1999
Opt for auto renewal and save Rs. 300 Renews automatically
₹1999
What you get on BS Premium?
- Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
- Pick your 5 favourite companies, get a daily email with all news updates on them.
- Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
- Preferential invites to Business Standard events.
- Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
Need More Information - write to us at assist@bsmail.in